Journal Name: Journal of Blood Disorders and Malignancies
ISSN:
DOI: 10.31021
Journal Type: Open Access
Contact Us: Click Here
Yusheng Zhu
Professor,United States
Eva Segelov
Professor,Australia
Alexander Birbrair
Professor,Brazil
Ewelina Grywalska
Assoc. Professor,Poland
Masood A. Shammas
Scientist,United States
Lívia Dickson Chen
Scientist,Brazil
Anil Tombak
Assoc. Professor,Turkey
Md. Sohrab Hossain
Adjunct Assistant Professor,United States
Mousa Ahmad Sulieman Qatawneh
Senior Specialist at Royal Medical Services,Jordan
The Journal of Blood Disorders and Malignancies (JBDM) is an international, peer-reviewed, open access journal published by Boffin Access Limited. The journal is dedicated to advancing knowledge in hematology and oncology by providing a global platform for researchers, clinicians, and healthcare professionals to publish high-quality studies on blood diseases and related malignancies.
JBDM bridges basic science, translational research, and clinical practice to foster innovations that improve diagnosis, treatment, and patient outcomes.
The Journal of Blood Disorders and Malignancies welcomes submissions in all areas of hematology and oncology, including but not limited to:
Hematopoiesis, stem cell biology, and bone marrow studies
Anemia, hemoglobinopathies, and red blood cell disorders
Platelet function, thrombosis, and coagulation disorders
Leukemia, lymphoma, and multiple myeloma
Myelodysplastic syndromes and myeloproliferative neoplasms
Pediatric hematology and rare blood diseases
Advances in hematopoietic stem cell transplantation
Hematologic malignancies: molecular and genetic mechanisms
Novel targeted therapies, immunotherapy, and CAR-T cell approaches
Hematology in precision medicine and personalized treatment
Supportive care, transfusion medicine, and palliative strategies
Clinical trials, case reports, and therapeutic innovations in hematology and oncology
Global Reach – Open access ensures your work is freely accessible to hematologists, oncologists, and researchers worldwide.
Rigorous Peer Review – Manuscripts undergo double-blind peer review for fairness, quality, and originality.
Rapid Publication – Accepted articles are published online promptly for timely dissemination.
Expert Editorial Board – Led by distinguished hematologists and oncologists with diverse expertise.
Translational Impact – Connecting fundamental research with clinical applications to advance patient care.
Author Rights – Authors retain copyright under Creative Commons licensing, allowing wide reuse and citation.
Enhanced Visibility – Articles benefit from indexing, academic promotion, and digital distribution for maximum impact.
The Journal of Blood Disorders and Malignancies strictly follows the ethical publishing principles outlined by COPE and ICMJE. Editorial decisions are based solely on scientific merit, with confidentiality, transparency, and integrity maintained throughout the review process.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.
